synlab Nuremberg has put the five thousandth Immulite 2000 Analyzer sold by Siemens worldwide into operation. Franconia's largest laboratory center serves some 1,000 physicians and nine clinics in the region. synlab will primarily use the Immulite 2000 Diagnostic System to test blood and serum samples for heart disease and allergies.
"With the Immulite 2000 from Siemens, we now have one of the most efficient immunoassay analyzers currently on the market", said Alexander Hoffmann, CEO of MVZ synlab Nuremberg. "What I especially appreciate about this device is its outstanding sensitivity and the fact that all process steps from pipetting, incubation, reading the sample and evaluation are fully automated. The personnel capacity required to process samples is thus lower than before."
"We are pleased that we were able to extend our cooperation with synlab. We are convinced that, with their wide spectrum of parameters, our immunoassay systems will make an important contribution to improving health", said Stefan Wolf, Regional Vice President EMEA I und General Manager of Siemens Healthcare Diagnostics in Germany. "Believe it or not, 70 percent of all clinical decisions made by physicians are based on the results of in vitro examinations, however, only two percent of all health-related expenditures are invested in this area. That clearly underscores the benefits that laboratory diagnostics yield for healthcare!" Siemens is the global market leader in immunoassay systems.
Siemens analytical systems contribute to the improvement of healthcare throughout the world and help to detect diseases in an early stage as well as to monitor the course of diseases. The Immulite 2000 is an analytical system for medical diagnostic laboratories that can be used to perform automated tests. This device is one of the most versatile immunoassay systems available on the international laboratory diagnostics market. For example, it can be used to test 450 different allergens. One of its special features is an innvotive patient test for diagnosing sepsis and cardiological diseases. This device has been on the market since 1998, and is now in operation in almost 200 countries worldwide.
synlab Nuremberg offers the entire spectrum of modern laboratory medicine to the physicians of Central Franconia. The focus is on STD diagnostics and gynecological endocrinology. Sample pick-up and report transfer services tailored to the needs of customer practices are understood as the basis for synlab laboratory services. Support of the Central Franconian regional company is provided at Fuerther Strasse 212; some 80 qualified medical employees are employed at Rohrmannstr. 12.
Siemens Healthcare is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion.
UTSA study describes new minimally invasive device to treat cancer and other illnesses
02.12.2016 | University of Texas at San Antonio
Earlier Alzheimer's diagnosis may be possible with new imaging compound
02.11.2016 | Washington University School of Medicine
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy